Baillie Gifford & Co
OPK icon

Baillie Gifford & Co’s Opko Health OPK Stock Holding History

Baillie Gifford & Co’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,635
Closed -$9.69K – 397
2023
Q1 		$9.69K Hold
6,635
– – ﹤0.01% 400
2022
Q4 		$8.29K Hold
6,635
– – ﹤0.01% 425
2022
Q3 		$13K Hold
6,635
– – ﹤0.01% 385
2022
Q2 		$17K Hold
6,635
– – ﹤0.01% 357
2022
Q1 		$23K Hold
6,635
– – ﹤0.01% 354
2021
Q4 		$32K Hold
6,635
– – ﹤0.01% 318
2021
Q3 		$24K Sell
6,635
-665
-9% -$2.48K ﹤0.01% 344
2021
Q2 		$30K Hold
7,300
– – ﹤0.01% 316
2021
Q1 		$31K Buy
+7,300
New +$34.9K ﹤0.01% 300

Other funds holding OPK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Baillie Gifford & Co's OPK Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Opko Health (OPK) in Q2 2023, closing a stake of 6,635 shares — an estimated $9.69K sold.

Baillie Gifford & Co first reported a position in OPK in Q1 2021 and held it in 9 quarters. The position peaked at $32K in Q4 2021. 230 funds tracked by Wall St. Rank hold OPK as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Opko Health position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 6,635 Opko Health shares in Q2 2023, an estimated $9.69K.
  • Baillie Gifford & Co first reported a position in Opko Health in Q1 2021 and held it in 9 quarters.
  • Baillie Gifford & Co's Opko Health position peaked at $32K in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Opko Health as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.